Search Results - Gillard, Pieter
- Showing 1 - 18 results of 18
-
1
-
2
Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies by Gillard, Pieter, Huurman, Volkert, Van der Auwera, Bart, Decallonne, Brigitte, Poppe, Kris, Roep, Bart O., Gorus, Frans, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Published 2009Text -
3
Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia by De Paep, Diedert L., Van Hulle, Freya, Ling, Zhidong, Vanhoeij, Marian, Hilbrands, Robert, Distelmans, Wim, Gillard, Pieter, Keymeulen, Bart, Pipeleers, Daniel, Jacobs-Tulleneers-Thevissen, Daniel
Published 2022Text -
4
Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients by Gillard, Pieter, Hilbrands, Robert, Van de Velde, Ursule, Ling, Zhidong, Lee, Da Hae, Weets, Ilse, Gorus, Frans, De Block, Christophe, Kaufman, Leonard, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Published 2013Text -
5
Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients by Ling, Zhidong, De Pauw, Pieter, Jacobs-Tulleneers-Thevissen, Daniel, Mao, Rui, Gillard, Pieter, Hampe, Christiane S., Martens, Geert A., In't Veld, Peter, Lernmark, Åke, Keymeulen, Bart, Gorus, Frans, Pipeleers, Daniel
Published 2015Text -
6
Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives by Vandewalle, Julie, Van der Auwera, Bart J., Amin, Henna, Quartier, Erik, Desouter, Aster K., Tenoutasse, Sylvie, Gillard, Pieter, De Block, Christophe, Keymeulen, Bart, Gorus, Frans K., Van de Casteele, Mark
Published 2021Text -
7
Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio by Van Dalem, Annelien, Demeester, Simke, Balti, Eric V., Keymeulen, Bart, Gillard, Pieter, Lapauw, Bruno, De Block, Christophe, Abrams, Pascale, Weber, Eric, Vermeulen, Ilse, De Pauw, Pieter, Pipeleers, Daniël, Weets, Ilse, Gorus, Frans K.
Published 2016Text -
8
Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio by Van Dalem, Annelien, Demeester, Simke, Balti, Eric V., Keymeulen, Bart, Gillard, Pieter, Lapauw, Bruno, De Block, Christophe, Abrams, Pascale, Weber, Eric, Vermeulen, Ilse, De Pauw, Pieter, Pipeleers, Daniël, Weets, Ilse, Gorus, Frans K.
Published 2017Text -
9
Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D by Roels, Sarah, Costa, Olivier R, Tersey, Sarah A, Stangé, Geert, De Smet, Dieter, Balti, Eric V, Gillard, Pieter, Keymeulen, Bart, Ling, Zhidong, Pipeleers, Daniel G, Gorus, Frans K, Mirmira, Raghavendra G, Martens, Geert A
Published 2018Text -
10
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes by Keymeulen, Bart, van Maurik, André, Inman, Dave, Oliveira, João, McLaughlin, Rene, Gittelman, Rachel M., Roep, Bart O., Gillard, Pieter, Hilbrands, Robert, Gorus, Frans, Mathieu, Chantal, Van de Velde, Ursule, Wisniacki, Nicolas, Napolitano, Antonella
Published 2020Text -
11
Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft by Keymeulen, Bart, Gillard, Pieter, Mathieu, Chantal, Movahedi, Babak, Maleux, Geert, Delvaux, Georges, Ysebaert, Dirk, Roep, Bart, Vandemeulebroucke, Evy, Marichal, Miriam, In 't Veld, Peter, Bogdani, Marika, Hendrieckx, Christel, Gorus, Frans, Ling, Zhidong, van Rood, Jon, Pipeleers, Daniel
Published 2006Text -
12
Identification of Donor Origin and Condition of Transplanted Islets in Situ in the Liver of a Type 1 Diabetic Recipient by Van Der Torren, Cornelis R., Suwandi, Jessica S., Lee, Dahae, Van't Wout, Ernst-Jan T., Duinkerken, Gaby, Swings, Godelieve, Mulder, Arend, Claas, Frans H. J., Ling, Zhidong, Gillard, Pieter, Keymeulen, Bart, Veld, Peter In't, Roep, Bart O.
Published 2017Text -
13
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA(1c) and Insulin Use: An Analysis From the FIDELIO-DKD Study by Rossing, Peter, Burgess, Ellen, Agarwal, Rajiv, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M., Gillard, Pieter, MacIsaac, Richard J., Wainstein, Julio, Joseph, Amer, Brinker, Meike, Roessig, Lothar, Scott, Charlie, Bakris, George L.
Published 2022Text -
14
Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project by Schliess, Freimut, Heise, Tim, Benesch, Carsten, Mianowska, Beata, Stegbauer, Constance, Broge, Björn, Gillard, Pieter, Binkley, George, Crône, Véronique, Carlier, Sébastien, Delval, Cécile, Petkov, Anton, Beck, Jan-Philipp, Lodwig, Volker, Gurdala, Mikolaj, Szecsenyi, Joachim, Rosenmöller, Magda, Cypryk, Katarzyna, Mathieu, Chantal, Renard, Eric, Heinemann, Lutz
Published 2018Text -
15
Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients by Hilbrands, Robert, Huurman, Volkert A.L., Gillard, Pieter, Velthuis, Jurjen H.L., De Waele, Marc, Mathieu, Chantal, Kaufman, Leonard, Pipeleers-Marichal, Miriam, Ling, Zhidong, Movahedi, Babak, Jacobs-Tulleneers-Thevissen, Daniel, Monbaliu, Diethard, Ysebaert, Dirk, Gorus, Frans K., Roep, Bart O., Pipeleers, Daniel G., Keymeulen, Bart
Published 2009Text -
16
Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation by Huurman, Volkert A. L., Hilbrands, Robert, Pinkse, Gabriëlle G. M., Gillard, Pieter, Duinkerken, Gaby, van de Linde, Pieter, van der Meer-Prins, Petronella M. W., Versteeg-van der Voort Maarschalk, Minke F. J., Verbeeck, Koen, Alizadeh, Behrooz Z., Mathieu, Chantal, Gorus, Frans K., Roelen, Dave L., Claas, Frans H. J., Keymeulen, Bart, Pipeleers, Daniel G., Roep, Bart O.
Published 2008Text -
17
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Asso... by Moser, Othmar, Riddell, Michael C., Eckstein, Max L., Adolfsson, Peter, Rabasa‐Lhoret, Rémi, van den Boom, Louisa, Gillard, Pieter, Nørgaard, Kirsten, Oliver, Nick S., Zaharieva, Dessi P., Battelino, Tadej, de Beaufort, Carine, Bergenstal, Richard M., Buckingham, Bruce, Cengiz, Eda, Deeb, Asma, Heise, Tim, Heller, Simon, Kowalski, Aaron J., Leelarathna, Lalantha, Mathieu, Chantal, Stettler, Christoph, Tauschmann, Martin, Thabit, Hood, Wilmot, Emma G., Sourij, Harald, Smart, Carmel E., Jacobs, Peter G., Bracken, Richard M., Mader, Julia K.
Published 2020Text -
18
Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter] by Moser, Othmar, Riddell, Michael C., Eckstein, Max L., Adolfsson, Peter, Rabasa-Lhoret, Rémi, van den Boom, Louisa, Gillard, Pieter, Nørgaard, Kirsten, Oliver, Nick S., Zaharieva, Dessi P., Battelino, Tadej, de Beaufort, Carine, Bergenstal, Richard M., Buckingham, Bruce, Cengiz, Eda, Deeb, Asma, Heise, Tim, Heller, Simon, Kowalski, Aaron J., Leelarathna, Lalantha, Mathieu, Chantal, Stettler, Christoph, Tauschmann, Martin, Thabit, Hood, Wilmot, Emma G., Sourij, Harald, Smart, Carmel E., Jacobs, Peter G., Bracken, Richard M., Mader, Julia K.
Published 2021Text